Efficacy News and Research

RSS
Concentric Medical announces treatment of first stroke patient with Merci Retriever

Concentric Medical announces treatment of first stroke patient with Merci Retriever

Health Canada grants Osiris Priority Review for Prochymal NDS

Health Canada grants Osiris Priority Review for Prochymal NDS

WHO, UNAIDS and PSI call for scale up of male circumcision in Eastern, Southern Africa

WHO, UNAIDS and PSI call for scale up of male circumcision in Eastern, Southern Africa

Major turning point in antiepileptic drug testing, development

Major turning point in antiepileptic drug testing, development

Gilead Sciences second-quarter total revenues increase 17% to $1.93 billion

Gilead Sciences second-quarter total revenues increase 17% to $1.93 billion

FDA accepts MannKind's resubmission of AFREZZA NDA, sets PDUFA action date

FDA accepts MannKind's resubmission of AFREZZA NDA, sets PDUFA action date

Arcion reports top-line results from ARC-4558 Phase 2b clinical trial for painful diabetic neuropathy

Arcion reports top-line results from ARC-4558 Phase 2b clinical trial for painful diabetic neuropathy

Archer Biosciences initiates third drug-escalation cohort in TPI-287 trial for metastatic melanoma

Archer Biosciences initiates third drug-escalation cohort in TPI-287 trial for metastatic melanoma

Biogen Idec second-quarter revenues increase 11% to $1.2 billion

Biogen Idec second-quarter revenues increase 11% to $1.2 billion

Tenofovir gel reduces HIV by 39% in women: CAPRISA 004 study

Tenofovir gel reduces HIV by 39% in women: CAPRISA 004 study

NanoViricides presents study results of nanoviricides anti-Ebola agents

NanoViricides presents study results of nanoviricides anti-Ebola agents

New report compares efficacy of Plavix, Effient in treating patients with ACS

New report compares efficacy of Plavix, Effient in treating patients with ACS

Bill Gates calls for renewed focus on reducing new HIV infections

Bill Gates calls for renewed focus on reducing new HIV infections

CytRx updates on progress in clinical development of bafetinib in three oncology indications

CytRx updates on progress in clinical development of bafetinib in three oncology indications

Vertos Medical announces 12-week data from MiDAS I clinical study for lumbar spinal stenosis

Vertos Medical announces 12-week data from MiDAS I clinical study for lumbar spinal stenosis

ZIOPHARM Oncology commences palifosfamide Phase III clinical trial for metastatic soft tissue sarcoma

ZIOPHARM Oncology commences palifosfamide Phase III clinical trial for metastatic soft tissue sarcoma

T-SPOT.TB test predicts TB infected persons better than TST: Study

T-SPOT.TB test predicts TB infected persons better than TST: Study

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna

ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna

ICON opens purpose-built clinical pharmacology unit within CMFT campus

ICON opens purpose-built clinical pharmacology unit within CMFT campus

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.